Reflecting on Genomic Testing in Practice for Breast Cancer
Joyce O’Shaughnessy, MD and Erin Cobain, MD, offer their reflections of genomic testing in breast cancer and its impact on clinical practice.
EP: 1.Evolving Treatment Paradigms for Early-Stage Breast Cancers
EP: 2.Overview of Genomic Assays for Early-Stage Breast Cancer
EP: 3.MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer
EP: 4.Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer
EP: 5.FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer
EP: 6.Exploring Multigene Genomic Assays in High-Risk BC Patients
EP: 7.Real-World Evidence in Genomic Testing from SABCS 2023
EP: 8.Racial Disparities and Genomic Testing for Breast Cancer Patients
Now Viewing
EP: 9.Reflecting on Genomic Testing in Practice for Breast Cancer
EP: 10.Ongoing Studies in Genomic Testing for Breast Cancer
Related Videos
Related Content
